Evidence map›Paper›PMID 30349857›Full record

ArticleAnnals of clinical and translational neurology2018

Heterogeneity in association of remote herpesvirus infections and pediatric MS.

Bardia Nourbakhsh, Alice Rutatangwa, Michael Waltz, Mary Rensel, Manikum Moodley, Jennifer Graves, Theron Charles Casper, Amy Waldman, Anita Belman, Benjamin Greenberg and 24 more

Open access · goldAbstract read
In one paragraph

Article in Annals of clinical and translational neurology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. A new clustering method identifies multiple sclerosis-specific T-cell receptors.Annals of clinical and translational neurology · 2021
    Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Environmental and genetic risk factors for MS: an integrated review.Annals of clinical and translational neurology · 2019
    Review
  17. Multiple sclerosis journal - experimental, translational and clinical
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

34 authors at 20 institutions in 1 country.

Bardia NourbakhshDepartment of Neurology Johns Hopkins University Baltimore Maryland.
Alice RutatangwaDepartment of Neurology Stony Brook University Hospital Stony Brook New York.
Michael WaltzDepartment of Pediatrics University of Utah Salt Lake City Utah.
Mary RenselMellen Center for Multiple Sclerosis Cleveland Clinic Cleveland Ohio.
Manikum MoodleyMellen Center for Multiple Sclerosis Cleveland Clinic Cleveland Ohio.
Jennifer GravesUCSF Regional Pediatric MS Center San Francisco California.
Theron Charles CasperDepartment of Pediatrics University of Utah Salt Lake City Utah.
Amy WaldmanChildren's Hospital of Philadelphia Philadelphia Pennsylvania.
Anita BelmanLourie Center for Pediatric MS at Stony Brook University Hospital Stony Brook New York.
Benjamin GreenbergUniversity of Texas Southwestern Medical Center Dallas Texas.
Manu GoyalWashington University Pediatric MS and other Demyelinating Disease Center Washington University in St. Louis St. Louis Missouri.
Yolanda HarrisCenter for Pediatric-Onset Demyelinating Disease at the Children's of Alabama University of Alabama Birmingham Alabama.
Ilana KahnChildren's National Medical Center Washington District of Columbia.
Timothy LotzeThe Blue Bird Circle Clinic for Multiple Sclerosis Texas Children's Hospital Baylor College of Medicine Houston Texas.
Soe MarWashington University Pediatric MS and other Demyelinating Disease Center Washington University in St. Louis St. Louis Missouri.
Teri SchreinerRocky Mountain MS Center Children's Hospital Colorado University of Colorado at Denver Aurora Colorado.
Gregory AaenPediatric Multiple Sclerosis Center at Loma Linda University Children's Hospital Loma Linda University Loma Linda California.
Janace HartUCSF Regional Pediatric MS Center San Francisco California.
Jayne NessCenter for Pediatric-Onset Demyelinating Disease at the Children's of Alabama University of Alabama Birmingham Alabama.
Jennifer RubinLurie Children's Hospital of Chicago Chicago Illinois.
Jan-Mendelt TillemaMayo Clinic Pediatric MS Center Mayo Clinic Rochester Minnesota.
Lauren KruppPediatric MS Center New York University New York New York.
Mark GormanPediatric Multiple Sclerosis and Related Disorders Program at Boston Children's Hospital Harvard Medical School Boston Massachusetts.
Leslie BensonPediatric Multiple Sclerosis and Related Disorders Program at Boston Children's Hospital Harvard Medical School Boston Massachusetts.
Moses RodriguezMayo Clinic Pediatric MS Center Mayo Clinic Rochester Minnesota.
Tanuja ChitnisPartners Pediatric MS Center Massachusetts General Hospital Boston Massachusetts.
John RoseDepartment of Neurology University of Utah Salt Lake City Utah.
Meghan CandeePrimary Children's Hospital University of Utah Salt Lake City Utah.
Bianca Weinstock-GuttmanThe Pediatric MS Center at the Jacobs Neurological Institute State University of New York at Buffalo Buffalo New York.
Xiaorong ShaoSchool of Public Health University of California, Berkeley Berkeley California.
Lisa BarcellosSchool of Public Health University of California, Berkeley Berkeley California.
Judith JamesUniversity of Oklahoma Health Sciences Center Oklahoma City Oklahoma.
Emmanuelle WaubantUCSF Regional Pediatric MS Center San Francisco California.
US Network of Pediatric MS Centers
University of Utah · USUniversity of California, San Francisco · USBerkeley Public Health Division · USCleveland Clinic · USMayo Clinic in Florida · USStony Brook University Hospital · USWashington University in St. Louis · USBaylor College of Medicine · USBoston Children's Hospital · USChildren's Hospital of Philadelphia · USChildren's National · USChildren's of Alabama · USHarvard University · USJohns Hopkins University · USLoma Linda University Children's Hospital · USLurie Children's Hospital · USMass General Brigham · USNew York University · USRocky Mountain MS Center · USThe University of Texas Southwestern Medical Center · US

Funding

Tracking and Evaluation CoreU54GM104938 · NIGMS · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Valerie Williams · 2013 to 2026
$68.2M
Utah Center for Clinical and Translational ScienceUL1TR002538 · NCATS · UNIVERSITY OF UTAH · PI HESS, RACHEL, MAJERSIK, JENNIFER JUHL · 2018 to 2022
$26.0M
Environmental and genetic risk factors for pediatric MSR01NS071463 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WAUBANT, EMMANUELLE LAURENCE · 2010 to 2015
$2.8M
NCATS NIH HHS UL1 TR002538NIGMS NIH HHS U54 GM104938NINDS NIH HHS R01 NS071463
6 · The paper itself

Abstract

objectiveWhile prior Epstein-Barr virus (EBV) infection has been consistently associated with subsequent risk of developing multiple sclerosis (MS), the association with other common herpesviruses has been more controversial. Our objectives were to determine whether remote infection with EBV and other common herpesviruses affect the susceptibility to pediatric MS and if there are interactions between genetic and demographic factors and viral infections.

methodsCases with pediatric-onset MS or clinically isolated syndrome within 4 years of disease onset, and controls were recruited from 16 American pediatric MS centers. Logistic regression models adjusted for potential confounders assessed the association between case status and serological evidence for past infection with EBV, cytomegalovirus (CMV), Herpes Simplex viruses-1 (HSV-1) and -2. We determined the heterogeneity of the effect of viral infection on the risk of having MS according to race, ethnicity and

resultsA total of 356 pediatric cases and 493 controls were recruited. In multivariable models, EBV-viral capsid antigen (VCA) seropositivity was associated with increased odds of having MS by 7.4 times (95% CI: 4.5-12.0,

interpretationEBV seropositivity is strongly associated with pediatric MS, as is HSV-1 seropositivity in subjects negative for

Identifiers

PMID30349857
PMCPMC6186938
OpenAlexW2890550983

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.